BIOMAT Database Logo BIOMAT Database Logo

Quantitative evaluation of L-[methyl-C-11] methionine uptake in tumor using positron emission tomography. 1989

J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Department of Neurosurgery, Tohoku University, School of Medicine, Japan.

Tumor uptake of L-[methyl-11C]methionine ([11C]Met) was assessed in six patients with brain tumors and three patients with lung cancer using positron emission tomography (PET). In arterial plasma samples taken at 5, 15, 30, and 60 min after injection, a fraction of [11C]Met was measured using high performance liquid chromatography in individual patients. Employing curve fitting, a history of [11C]Met activity was obtained as an input function. By means of sequential PET scannings and graphic analysis, uptake rate and distribution volume of [11C]Met in tumor tissue were calculated. In two studies irreversible uptake into the tumors was not seen when total plasma 11C activity was used as the input; however when [11C]Met plasma activity was used, definite irreversible uptake was seen, indicating tumor viability. In other studies, up to 24% underestimation of uptake rate was found. The present results demonstrated the importance of measuring [11C]Met in plasma for quantitative assessment of in vivo amino acid metabolism in tumors.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008657 Metabolic Clearance Rate Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. Total Body Clearance Rate,Clearance Rate, Metabolic,Clearance Rates, Metabolic,Metabolic Clearance Rates,Rate, Metabolic Clearance,Rates, Metabolic Clearance
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001932 Brain Neoplasms Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain. Brain Cancer,Brain Metastases,Brain Tumors,Cancer of Brain,Malignant Primary Brain Tumors,Neoplasms, Intracranial,Benign Neoplasms, Brain,Brain Neoplasm, Primary,Brain Neoplasms, Benign,Brain Neoplasms, Malignant,Brain Neoplasms, Malignant, Primary,Brain Neoplasms, Primary Malignant,Brain Tumor, Primary,Brain Tumor, Recurrent,Cancer of the Brain,Intracranial Neoplasms,Malignant Neoplasms, Brain,Malignant Primary Brain Neoplasms,Neoplasms, Brain,Neoplasms, Brain, Benign,Neoplasms, Brain, Malignant,Neoplasms, Brain, Primary,Primary Brain Neoplasms,Primary Malignant Brain Neoplasms,Primary Malignant Brain Tumors,Benign Brain Neoplasm,Benign Brain Neoplasms,Benign Neoplasm, Brain,Brain Benign Neoplasm,Brain Benign Neoplasms,Brain Cancers,Brain Malignant Neoplasm,Brain Malignant Neoplasms,Brain Metastase,Brain Neoplasm,Brain Neoplasm, Benign,Brain Neoplasm, Malignant,Brain Neoplasms, Primary,Brain Tumor,Brain Tumors, Recurrent,Cancer, Brain,Intracranial Neoplasm,Malignant Brain Neoplasm,Malignant Brain Neoplasms,Malignant Neoplasm, Brain,Neoplasm, Brain,Neoplasm, Intracranial,Primary Brain Neoplasm,Primary Brain Tumor,Primary Brain Tumors,Recurrent Brain Tumor,Recurrent Brain Tumors,Tumor, Brain
D002250 Carbon Radioisotopes Unstable isotopes of carbon that decay or disintegrate emitting radiation. C atoms with atomic weights 10, 11, and 14-16 are radioactive carbon isotopes. Radioisotopes, Carbon
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Lung tumor imaging by positron emission tomography using C-11 L-methionine.
January 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Determination of brain tumor recurrence using 11 C-methionine positron emission tomography after radiotherapy.
October 2021, Cancer science,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
L-[Methyl-11C] Methionine-Positron-Emission Tomography (MET-PET).
January 2019, Methods in molecular biology (Clifton, N.J.),
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Meningioma treated with interferon-alpha, evaluated with [(11)C]-L-methionine positron emission tomography.
August 2001, Clinical cancer research : an official journal of the American Association for Cancer Research,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Amino acid study of cerebral gliomas using positron emission tomography--analysis of (11C-methyl)-L-methionine uptake index.
December 1990, Neurologia medico-chirurgica,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Clinical application of (11)C-methionine positron emission tomography for evaluation of pancreatic function.
July 2002, Pancreas,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
l-[METHYL-(11)C] methionine positron emission tomography for target delineation in malignant gliomas: impact on results of carbon ion radiotherapy.
February 2008, International journal of radiation oncology, biology, physics,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Targeting optimal biopsy location in basal ganglia germinoma using (11)C-methionine positron emission tomography.
October 2008, Surgical neurology,
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
(11)C-Methionine positron emission tomography may monitor the activity of encephalitis.
December 2012, Acta radiologica (Stockholm, Sweden : 1987),
J Hatazawa, and K Ishiwata, and M Itoh, and M Kameyama, and K Kubota, and T Ido, and T Matsuzawa, and T Yoshimoto, and S Watanuki, and S Seo
Innovative approach in the diagnosis of gliomatosis cerebri using carbon-11-L-methionine positron emission tomography.
April 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Copied contents to your clipboard!